基于应用程序的步行计划对韩国炎症性肠道疾病的肥胖患者的有效性:单盲并行组随机临床试验
Young Jin Lee1, Eun Ja Kwon2, Da-In Park3
1College of Nursing, Eulji University, 712, Dongil-ro, Uijeongbu, Gyeonggi-do, 117759, Republic of Korea.
BMC gastroenterology
|May 30, 2025
概括
使用移动应用程序进行了为期10周的步行计划,有效地减少了炎症性肠病 (IBD) 的肥胖患者的身体脂肪. 这种干预措施有望改善该人口的体重管理和健康结果.
科学领域:
- 临床医学 临床医学
- 运动生理学 运动生理学
- 胃肠病学 胃肠病学
背景情况:
- 肥胖使炎症性肠病 (IBD) 管理复杂化,症状恶化和并发症增加.
- 有效的体重管理策略对于IBD患者至关重要.
- 这项研究解决了对肥胖IBD个体有针对性的干预措施的需要.
研究的目的:
- 为肥胖IBD患者开发和实施为期10周的移动应用程序辅助步行计划.
- 评估该计划在体重管理中的有效性.
- 评估对身体组成,压力,疲劳和生活质量的影响.
主要方法:
- 一个单盲,并行组随机临床试验,涉及54名肥胖IBD参与者.
- 干预组:通过移动应用程序提供10周的计划,每天有7000多步 (每周5天),再加上教育材料.
- 控制组:标准的护理. 主要结局:BMI,身体脂肪百分比,骨肌肉质量. 二次结果:感知到的压力,疲劳,生活质量.
主要成果:
- 49名参与者完成了数据收集.
- 与对照组相比,干预组的BMI (p=.001) 和身体脂肪百分比 (p=.002) 显著降低.
- 干预组内观察到明显减少感知到的压力 (p=.038) 和疲劳 (p=.047),但与对照组没有显著差异.
结论:
- 一个为期10周的步行计划与移动应用程序支持有效地减少了肥胖IBD患者的身体脂肪.
- 这项干预表明了改善IBD临床环境中的健康管理的潜力.
- 需要进一步的研究来研究对肌肉质量和心理变量的影响.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
432
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
432
01:30Inflammatory Bowel Disease II: Crohn's Disease
402
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
402
01:29Inflammatory Bowel Disease IV: Pharmacological Management
205
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
205
01:21Inflammatory Bowel Disease V: Surgical Management
226
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
226
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
212
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
212
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278